Market Cap (In USD)
424.63 Thousand
Revenue (In USD)
-
Net Income (In USD)
-239.11 Thousand
Avg. Volume
8503.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.004-0.05
- PE
- -
- EPS
- -
- Beta Value
- 0.749
- ISIN
- US65343D1000
- CUSIP
- 65343D100
- CIK
- 1625288
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Richard S. Greenberg
- Employee Count
- -
- Website
- https://www.nexienbiopharma.com
- Ipo Date
- 2017-11-29
- Details
- Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
More Stocks
-
5918
-
BRKWFBrickworks Limited
BRKWF
-
TRMLFTourmaline Oil Corp.
TRMLF
-
JSDAJones Soda Co.
JSDA
-
RIWIRIWI Corp.
RIWI
-
JEXYY
-
PATELSAIPatels Airtemp (India) Limited
PATELSAI
-
0HD0Ally Financial Inc.
0HD0